Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 28, 2021

SELL
$2.62 - $5.43 $115 - $238
-44 Closed
0 $0
Q2 2021

Jul 26, 2021

SELL
$5.06 - $8.15 $3,056 - $4,922
-604 Reduced 93.21%
44 $0
Q1 2021

Apr 30, 2021

BUY
$6.24 - $9.58 $3,188 - $4,895
511 Added 372.99%
648 $4,000
Q4 2020

Feb 11, 2021

SELL
$6.28 - $8.79 $540 - $755
-86 Reduced 38.57%
137 $1,000
Q3 2020

Nov 03, 2020

BUY
$7.5 - $11.11 $1,140 - $1,688
152 Added 214.08%
223 $2,000
Q2 2020

Jul 30, 2020

BUY
$8.33 - $13.79 $591 - $979
71 New
71 $1,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Kala Pharmaceuticals, Inc.


  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $8.67M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.